对于催酸诱导的过敏反应,皮松预防的有用性:一项回顾性研究
Maho Tanaka1,2, Masato Komuro3, Yasushi Kojima4
1Department of Pharmacy, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
概括
预防性皮可以有效地预防接受氧沙化疗的结肠直肠癌患者的过敏反应. 这种策略允许继续治疗,并减少严重反应,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥克萨利普拉丁是结直肠癌的关键化疗剂.
- 过敏反应和不良反应使oxaliplatin治疗复杂化.
研究的目的:
- 为了评估预防性皮在预防oxaliplatin诱导的过敏反应的疗效.
- 评估皮预防对治疗延续的影响.
主要方法:
- 对370名接受氧沙治疗的结直肠癌患者的回顾性分析 (2017年1月至2023年12月).
- 常规前期治疗和皮预防组之间的过敏反应发生率和严重程度的比较.
- 当氧沙的累积剂量超过400mg/m2或治疗中断超过8周时,用100mg的皮松.
主要成果:
- 18/370名患者 (常规组) 与5/370名患者 (预防组) 发生过敏反应.
- 严重反应仅在常规组中观察到.
- 由于过敏症的治疗中止在预防组显着较低.
结论:
- 预防性皮是有效的预防oxaliplatin诱导的过敏反应.
- 这一策略支持继续使用氧沙治疗.
- 皮预防是一种潜在的方法来管理与氧沙相关的过敏症.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
606
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
606
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439


